5. Clinically significant cardiovascular disease such as uncontrolled or symptomatic arrhythmias, congestive heart failure or myocardial infarction within 6 months at the time of consent or any Class 3 (moderate) or 4 (severe) cardiac disease defined by the New York Heart Association Classification.